Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)
NCT06268522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121
Last updated 2026-01-29
Summary
This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.
Conditions
- Low Back Pain
Interventions
- BEHAVIORAL
-
Mindfulness-Oriented Recovery Enhancement: (MORE) group
Mindfulness-Oriented Recovery Enhancement (MORE) is a novel social work intervention and mental training program that unites complementary aspects of mindfulness training.
- BEHAVIORAL
-
Psychoeducation
Education on the neurobiology of pain, healthy eating, diet, sleep and stress
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2025-06-28
- Completion
- 2025-06-28
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
NCT01789970 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid Taper Study
NCT03912298 ·Status: COMPLETED
-
Developing and Pilot Testing an Opioid Tapering Protocol
NCT04257695 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
NCT01081912 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain
NCT00565760 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
NCT01922739 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Pain Relief in Low Back Pain
NCT00325949 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
NCT00763321 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Function in Men Treated for Pain With Opioids or Placebo
NCT00737737 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Open Label Placebo Rationales
NCT05952960 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Chronic Low Back Pain Study
NCT01364922 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
NCT00761150 ·Status: COMPLETED ·Phase: PHASE3
-
Patient-Centered Opioid Tapering Study
NCT03303209 ·Status: COMPLETED
-
Trial of Chronic Pain Self-Management in Clinic or Community for Low-Income Hispanics
NCT02906358 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users
NCT01596673 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
NCT01240863 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain
NCT00195728 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults
NCT03137030 ·Status: WITHDRAWN ·Phase: PHASE1
-
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
NCT01400139 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions
NCT00857142 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults
NCT03137017 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
NCT02259179 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen
NCT03567941 ·Status: COMPLETED ·Phase: PHASE1